Stridor Is an Independent Risk Factor for Mortality and Disease Progression in Patients with Multiple System Atrophy

Stridor is a critical prognostic factor in MSA, associated with higher mortality and worse disease progression, whereas SAS alone is not associated with a change in mortality. Patients undergoing CPAP therapy have a much better survival among those with stridor. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Authors

Institutions

Publication Details

Journal
Movement Disorders
Published
2025-10-07
DOI
https://doi.org/10.1002/mds.70080
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stridor Is an Independent Risk Factor for Mortality and Disease Progression in Patients with Multiple System Atrophy

Giulia Lazzeri, Anne Pavy‐Le Traon, Anna Delamarre, Margaux Dunoyer et al.
Movement Disorders
Parkinson's Disease Mechanisms and Treatments
article

Stridor Is an Independent Risk Factor for Mortality and Disease Progression in Patients with Multiple System Atrophy

Giulia Lazzeri, Anne Pavy‐Le Traon, Anna Delamarre, Margaux Dunoyer, Federico Sirna, Claire Georges, Pauline Dodet, David Bendetowicz, Maxime Patout, Olivier Rascol, David Grabli, Imad Ghorayeb, Rachel Debs, Cécile Proust‐Lima, Isabelle Arnulf, Margherita Fabbri, Wassilios G. Meissner, Alexandra Foubert‐Samier, Cécile Londner
article en

Abstract

Stridor is a critical prognostic factor in MSA, associated with higher mortality and worse disease progression, whereas SAS alone is not associated with a change in mortality. Patients undergoing CPAP therapy have a much better survival among those with stridor. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Movement DisordersVol. 41(1)
Centre National de la Recherche Scientifique (FR), Université de Bordeaux (FR), Inserm (FR), Université Fédérale de Toulouse Midi-Pyrénées (FR), University of Milan (IT), Centre Hospitalier Universitaire de Bordeaux (FR), Sorbonne Université (FR), Institut des Maladies Neurodégénératives (FR), Sorbonne Paris Cité (FR), Assistance Publique – Hôpitaux de Paris (FR), New Zealand Brain Research Institute (NZ), Clinical Investigation Center Plurithematic Tours (FR), Institut de Neurosciences Cognitives et Intégratives d’Aquitaine (FR), Parkinson's UK (GB), Bordeaux Population Health (FR), Pitié-Salpêtrière Hospital (FR), Institut de Psychiatrie et Neurosciences de Paris (FR), Hôpital Purpan (FR), Institut du Cerveau (FR), Centre d'Investigation Clinique Plurithématique de Bordeaux, University of Otago (NZ)
Openalex Percentile: Top 60%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.